» Authors » Alexander X Lozano

Alexander X Lozano

Explore the profile of Alexander X Lozano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 348
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang W, Zhang C, Wei K, Sang Y, Shen J, Wang G, et al.
Precis Clin Med . 2022 Jun; 4(1):62-69. PMID: 35693121
Within COVID-19 there is an urgent unmet need to predict at the time of hospital admission which COVID-19 patients will recover from the disease, and how fast they recover to...
2.
Lozano A, Chaudhuri A, Nene A, Bacchiocchi A, Earland N, Vesely M, et al.
Nat Med . 2022 Jan; 28(2):353-362. PMID: 35027754
Severe immune-related adverse events (irAEs) occur in up to 60% of patients with melanoma treated with immune checkpoint inhibitors (ICIs). However, it is unknown whether a common baseline immunological state...
3.
Nesvet J, Antilla K, Pancirer D, Lozano A, Preiss J, Ma W, et al.
Clin Chem . 2021 Jan; 67(3):534-542. PMID: 33393992
Background: Liquid biopsy circulating tumor DNA (ctDNA) mutational analysis holds great promises for precision medicine targeted therapy and more effective cancer management. However, its wide adoption is hampered by high...
4.
Chang W, Mashouri P, Lozano A, Johnstone B, Husic M, Olry A, et al.
Genet Med . 2020 Jun; 22(8):1427. PMID: 32555415
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
5.
Park S, Won D, Lee B, Escobedo D, Esteva A, Aalipour A, et al.
Nat Biomed Eng . 2020 May; 4(6):662. PMID: 32382068
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
6.
Chang W, Mashouri P, Lozano A, Johnstone B, Husic M, Olry A, et al.
Genet Med . 2020 May; 22(8):1391-1400. PMID: 32366968
Purpose: Computational documentation of genetic disorders is highly reliant on structured data for differential diagnosis, pathogenic variant identification, and patient matchmaking. However, most information on rare diseases (RDs) exists in...
7.
Aalipour A, Le Boeuf F, Tang M, Murty S, Simonetta F, Lozano A, et al.
Mol Ther Oncolytics . 2020 Apr; 17:232-240. PMID: 32346612
Chimeric antigen receptor (CAR) T cell therapy has had limited efficacy for solid tumors, largely due to a lack of selectively and highly expressed surface antigens. To avoid reliance on...
8.
Park S, Won D, Lee B, Escobedo D, Esteva A, Aalipour A, et al.
Nat Biomed Eng . 2020 Apr; 4(6):624-635. PMID: 32251391
Technologies for the longitudinal monitoring of a person's health are poorly integrated with clinical workflows, and have rarely produced actionable biometric data for healthcare providers. Here, we describe easily deployable...
9.
Antaris A, Chen H, Diao S, Ma Z, Zhang Z, Zhu S, et al.
Nat Commun . 2017 May; 8:15269. PMID: 28524850
Fluorescence imaging in the second near-infrared window (NIR-II) allows visualization of deep anatomical features with an unprecedented degree of clarity. NIR-II fluorophores draw from a broad spectrum of materials spanning...